- 4 October 2007 -

Membrana signs blood filtration agreement

Membrana has signed a supply agreement with Arbios Systems, Inc, a manufacturer of proprietary medical devices and cell-based therapies. The agreement provides for future exclusive supply by Membrana, and exclusive sourcing by Arbios, of membranes suitable for use in Arbios' SEPETtherapeutic blood filtration products for the treatment of liver failure and sepsis.

"Membrana's polyether sulphone (PES) microporous membrane technology is currently utilised in FDA-approved blood filtration cartridges for renal dialysis/hemofiltration indications, and we believe that they have excellent PES technology for our proprietary liver dialysis application," said Shawn Cain, interim president and CEO of Arbios.

"We are pleased to enter into this relationship with Arbios Systems as technology partner for its selective blood filtration membranes requirements for the SEPET product line,"added Josef Sauer, general manager of Membrana GmbH."We are very optimistic about the opportunity in the liver dialysis field and believe that Arbios has excellent technology for that important application."

www.membrana.com

This update is brought to you by Filtration Industry Analyst, the business information newsletter. To receive a sample copy of Filtration Industry Analyst, click here.